DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) Stock Price, Quote, News & History

DTCFFOTCQB

Trade with Public

$0.3374

-0.0201-5.62%

At close: Sep 11, 5:00 PM EST

$0.7000

0.36107.47%

After Hours: Jan 27, 4:01 PM EST

OverviewFinancials Sentiment Compare

Key Statistics

Open

$0.35

$0.34

Volume / Avg.

4.00K / 8.96K

Day Range

$0.34 - $0.35

52 Wk Range

0.25 - 0.78

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Defence Therapeutics Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.53M

Investing Cash Flow (TTM)

-30.05K

Financing Cash Flow (TTM)

5.44M

Free Cash Flow (TTM)

-4.55M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

873.32K

Valuation Metrics

Enterprise Value

$25.89M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

6.89

Earnings Yield % (TTM)

-20.30%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.05

Company Debt

Total Debt

$1.56M

LT Debt

$1.56M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

$140.98K

Total Cash

$2.95M

Debt to Equity

0.29

Issuance of Debt (TTM)

$2.13M

Repayment of Debt (TTM)

-$18.37K

Key Statistics

Open

$0.35

$0.34

Volume / Avg.

4.00K / 8.96K

Day Range

$0.34 - $0.35

52 Wk Range

0.25 - 0.78

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases....

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

DTCFF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

DTCFF

FAQ

How do I buy DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) stock?

You can purchase shares of DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (OTCQB:DTCFF) through any online brokerage.

View our list of the best stock brokerages

Who are DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) competitors?

There are no as such competitors for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.

What is the forecast, or price target, for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) stock?

There is no analysis for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC to provide a consensus price target.

What is the current price for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF)?

The stock price for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (OTCQB: DTCFF) is $0.3374 last updated September 11, 2026 at 3:59 PM EDT.

Does DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) pay a dividend?

There are no upcoming dividends for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.

When is DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (OTCQB:DTCFF) reporting earnings?

DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC does not have any upcoming earnings scheduled.

Is DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) going to split?

There is no upcoming split for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.

What sector and industry does DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (DTCFF) operate in?

DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.